Multiple Sclerosis Relapsing-remitting
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis Relapsing-remitting.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: A Study to Assess New Participant's Perspectives Beyond Clinical Efficacy of Monoclonal Antibody-Based Relapsing Remitting Multiple Sclerosis (RRMS) Treatments
A completed clinical trial examined participants' perspectives beyond clinical efficacy of monoclonal antibody–based treatments for relapsin…
-
CLINICAL_TRIALS research · 2022-04-22Clinical Trial Update: Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis [Phase 4]
A Phase 4 clinical trial update investigates the effects of hydroxyvitamin D3 on multiple sclerosis and related conditions.
-
CLINICAL_TRIALS research · 2021-10-26Clinical Trial Update: Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential [Phase 4]
Phase 4 trial update exploring mechanisms of action and neuroprotective potential of alemtuzumab in relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS research · 2019-08-12Clinical Trial Update: Evaluation of a Modified Paleolithic Dietary Intervention in the Treatment of Relapsing-Remitting Multiple Sclerosis [NA]
A completed clinical trial evaluating a modified Paleolithic dietary intervention for relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS research · 2011-10-18Clinical Trial Update: The Effects of Aerobics Training on Balance in Patients With Multiple Sclerosis [EARLY_Phase 1]
This clinical trial update describes a Phase 1 study examining whether aerobics training improves balance in relapsing-remitting multiple sc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.